Log In
Print
BCIQ
Print
Print this Print this
 

Vimovo (formerly PN 400)

  Manage Alerts
Collapse Summary General Information
Company Pozen Inc.
DescriptionFixed-dose combination of 500 mg esomeprazole, a proton pump inhibitor (PPI) plus 20 mg naproxen
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today